Standout Papers

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Adva... 2000 2026 2008 2017 1.6k
  1. Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study (2000)
    Hans von der Maase, Steen Werner Hansen et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 16 from Science/Nature 73 standout
Sub-graph 1 of 20

Citing Papers

Probiotic-guided CAR-T cells for solid tumor targeting
2023 StandoutScience
Y chromosome loss in cancer drives growth by evasion of adaptive immunity
2023 StandoutNature
3 intermediate papers

Works of Peter Wersäll being referenced

Long-Term Follow-Up of Allogeneic Hematopoietic Stem Cell Transplantation for Solid Cancer
2015
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
2000 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Peter Wersäll 1347 1158 552 1764 68 3.6k
Lisa Sengeløv 1033 1414 214 2085 45 3.4k
Johnny Kao 1183 1028 322 820 75 2.9k
Juergen Dunst 1499 1143 480 1471 117 3.9k
Haakon Ragde 2164 887 427 756 83 4.5k
Sandra Collette 3356 2302 409 2525 73 6.2k
Brian G. Czito 1391 1983 508 1647 150 3.5k
Svend Aage Engelholm 969 802 647 986 93 3.2k
Paul B. Gaudin 1947 451 740 622 46 3.1k
Thierry Gil 2071 1121 327 808 93 3.4k
Scott Saxman 1508 2422 212 2325 42 5.4k

All Works

Loading papers...

Rankless by CCL
2026